The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on nerves throughout the body. The federal agency said on Tuesday it greenlighted SpringWorks Therapeutics’s drug Gomekli for patients dealing with neurofibromatosis type 1 (NF1) “who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection.” …
Source link
FDA approves new genetic disorder drug
Date:
Share post:
More like thisRelated
Republicans weigh ending Wall Street’s favorite tax break
Republicans are considering doing away with one of...
Why red states are pulling ahead in America’s clean energy race
Renewable energy generation is surging across many of...
White House orders freeze on all federal financial assistance
The White House budget office has ordered a pause...
Trump says Gaza ceasefire should be cancelled if all Israeli hostages not freed | Donald Trump
Donald Trump has warned that if all the...